Here's What's New In The World Of Investing...

The Daily Dividend 11/4/25

November 04, 2025

In partnership with

Corporate mergers, arbitrage opportunities, dividend raises!

This is a heck of a week and it’s only Tuesday.

We’ve got plenty of exciting news in today’s dispatch. There’s a major merger in the works which may offer an enormous arbitrage opportunity. And, there are two stocks raising their dividends at a rate that outpaces inflation.

Let’s start with the acquisition first…

Kimberly-Clark Corporation ($KMB) To Buy Kenvue Inc. ($KVUE)

Huge news for consumer staples investors, and a possible arbitrage opportunity with plenty of upside — if everything goes well.

Yesterday, Kimberly-Clark Corporation announced their plans to acquire Kenvue Inc..

Kenvue Inc. is the consumer staple division of Johnson & Johnson that was spun-off into its own standalone company a few years back. The firm owns the Neutrogena, Listerine, Benadryl, and Band-Aid brands. But, Kenvue is also under fire due to claims that one of their products, Tylenol, can potentially cause autism.

Despite the Tylenol controversy, Kimberly-Clark Corporation plans to buy Kenvue in a $48.7 billion deal.

Under the agreement, Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark for each Kenvue share they own.

This potentially values Kenvue stock at $21.01 per share.

  • Acquisition date: H2 2026

Leidos Holdings, Inc. ($LDOS) Raises Dividend By 7.5%

Here’s a military tech stock that’s raising its dividend.

Leidos Holdings, Inc. is one of the defense industry’s largest IT services providers. The firm creates cyber security and surveillance systems. You may not know this company by name, but you’ve probably dealt with the firm’s products before. Most airport security X-ray machines are made by Leidos.

Recently, Leidos announced a 7.5% dividend increase.

Leidos Holdings, Inc. will now pay a $0.43/share quarterly dividend.

  • Ex-dividend date: 12/15/25

  • Payout date: 12/31/25

  • Forward starting dividend yield: 0.9%

AbbVie Inc. ($ABBV) Raises Dividend By 5.5%

This is one of the biggest drug companies in the world. And, by some metrics, the most successful stock spin-off of all-time.

AbbVie Inc. researches and develops pharmaceuticals. The company operates in the immunology, neuroscience, oncology, and eye care niches. And, AbbVie is responsible for creating some of the world’s most popular prescription drugs, including: Humira, Skyrizi, and Rinvoq.

Last week, AbbVie announced a 5.5% dividend increase.

AbbVie Inc. will now pay a $1.73/share quarterly dividend.

  • Ex-dividend date: 1/16/26

  • Payout date: 2/17/26

  • Forward starting dividend yield: 3.03%

Your career will thank you.

Over 4 million professionals start their day with Morning Brew—because business news doesn’t have to be boring.

Each daily email breaks down the biggest stories in business, tech, and finance with clarity, wit, and relevance—so you're not just informed, you're actually interested.

Whether you’re leading meetings or just trying to keep up, Morning Brew helps you talk the talk without digging through social media or jargon-packed articles. And odds are, it’s already sitting in your coworker’s inbox—so you’ll have plenty to chat about.

It’s 100% free and takes less than 15 seconds to sign up, so try it today and see how Morning Brew is transforming business media for the better.

As always, thank you for reading and have a great day investing!

P.S. Enjoying the newsletter? Forward it to a friend who loves dividends.

Disclaimer: This article is for entertainment purposes only. It is not financial advice, always do your own research.